Citations

Showing 10 of 108081 citations.

Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair
Nargesi, Arash Aghajani , Lerman, Lilach O. , Eirin, Alfonso , Eirin, Alfonso

Mayo Clinic

Current Gene Therapy | April 13, 2017 | Volume: 17 | Issue: 1 | Pages: No page available

10.2174/1566523217666170412110724 | PMID 28403795 Get It

A Methodology to Compare Insulin Dosing Recommendations in Real-Life Settings
Groat, Danielle , Thompson, Bithika , Neto, Pedro Cunha Mendes , Soni, Hiral , Boyle, Mary E., Bailey, Marilyn, Grando, Maria A, Cook, Curtiss B. , Grando, Adela

Mayo Clinic

Journal of Diabetes Science and Technology | April 13, 2017 | Volume: 11 | Issue: 6 | Pages: 1174-1182

10.1177/1932296817704444 | PMID 28406039 Get It

Background: We propose a methodology to analyze complex real-life glucose data in insulin pump users. Methods: Patients with type 1 diabetes (T1D) on insulin pumps were recruited from an academic endocrinology practice. Glucose data, insulin bolus (IB) amounts, and self-reported alcohol consumption and exercise events were collected for 30 days. Rules were developed to retrospectively compare IB recommendations from the insulin pump bolus calculator (IPBC) against recommendations from a proposed decision aid (PDA) and for assessing the PDA’s recommendation for exercise and alcohol. Results: Data from 15 participants were analyzed. When considering instances where glucose was below target, the PDA recommended a smaller dose in 14%, but a larger dose in 13% and an equivalent IB in 73%. For glucose levels at target, the PDA suggested an equivalent IB in 58% compared to the subject’s IPBC, but higher doses in 20% and lower in 22%. In events where postprandial glucose was higher than target, the PDA suggested higher doses in 25%, lower doses in 13%, and equivalent doses in 62%. In 64% of all alcohol events the PDA would have provided appropriate advice. In 75% of exercise events, the PDA appropriately advised an IB, a carbohydrate snack, or neither. Conclusions: This study provides a methodology to systematically analyze real-life data generated by insulin pumps and allowed a preliminary analysis of the performance of the PDA for insulin dosing. Further testing of the methodological approach in a broader diabetes population and prospective testing of the PDA are needed.
Critical Diagnoses in Forensic Pathology: Ethics of Disclosure
Blessing, Melissa M. , Reichard, R. Ross

Mayo Clinic

Academic Forensic Pathology | April 13, 2017 | Volume: 3 | Issue: 3 | Pages: 289-293

10.23907/2013.038 Get It

A complex set of systems exists in the United States to manage and regulate the practice of medicine, and forensic pathologists (FPs) are bound by the associated ethical guidelines and associated statutory obligations. Individual FPs, for example, are required to have and maintain a state medical license that requires continuing medical education and provides oversight of many aspects of the practice of medicine. The laboratories in which forensic pathology is practiced, however, generally do not have to be accredited. In contrast, the College of American Pathologists (CAP) is the recognized accrediting body that “regulates” the majority of anatomic pathology and laboratory medicine, including hospital (consented) autopsies. Unlike hospital-based pathology practices, few incentives are present that encourage or require forensic pathology practices to pursue accreditation. Since the preponderance of forensic pathology practices do not fall under the purview of CAP, this relatively small subset of pathologists are left to determine their own set of professional and ethical standards. The National Association of Medical Examiners (NAME) laboratory accreditation and published autopsy guidelines provides a foundation for development of a quality management program, but does not specifically address disclosure of test results. Defining “critical diagnoses” in forensic pathology is challenging, and communicating these important findings to the proper individual(s) or organizations may not fall under statutory or accrediting requirements, and thus may become an ethical issue for the medical examiner/coroner.
Update on Malaria Diagnostics and Test Utilization
Mathison, Blaine A. , Pritt, Bobbi S. , Pritt, Bobbi S , Mathison, Blaine A

Mayo Clinic

Journal of Clinical Microbiology | April 13, 2017 | Volume: 55 | Issue: 7 | Pages: 2009-2017

10.1128/jcm.02562-16 | PMID 28404673 Get It

ABSTRACT Malaria is a potentially life-threatening disease requiring rapid diagnosis and treatment. Although microscopic examination of thick and thin blood films remains the gold standard for laboratory diagnosis, rapid antigen tests and nucleic acid amplification methods may also play a useful role in detection of acute infection. This review discusses the advantages and disadvantages of the commonly used diagnostic methods and provides important practice points for optimal malaria test utilization.
Multicenter Performance Assessment of Carba NP Test
Cunningham, Scott A. , Limbago, Brandi, Traczewski, Maria M., Anderson, Karen, Hackel, Meredith , Hindler, Janet A., Sahm, Dan, Alyanak, Efe, Lawsin, Adrian , Man, Tom J. B. de , Mandrekar, Jayawant N. , Jenkins, Stephen G., Humphries, Romney M. , Palavecino, Elizabeth , Patel, Robin , Vasoo, Shawn , Gulvik, Christopher A. , Schuetz, Audrey N. , Patel, Robin , Humphries, Romney , Cunningham, Scott A

Mayo Clinic

Journal of Clinical Microbiology | April 13, 2017 | Volume: 55 | Issue: 6 | Pages: 1954-1960

10.1128/jcm.00244-17 | PMID 28404676 Get It

ABSTRACT Eighty Gram-negative bacilli (54 Enterobacteriaceae and 26 nonfermenting Gram-negative bacilli) obtained from multiple institutions in the United States were distributed in a blinded manner to seven testing laboratories to compare their performance of a test for detection of carbapenemase production, the Carba NP test. The Carba NP test was performed by all laboratories, following the Clinical and Laboratory Standards Institute (CLSI) procedure. Site-versus-site comparisons demonstrated a high level of consistency for the Carba NP assay, with just 3/21 site comparisons yielding a difference in sensitivity ( P < 0.05). Previously described limitations with bla OXA-48-like carbapenemases and bla OXA carbapenemases associated with Acinetobacter baumannii were noted. Based on these data, we demonstrate that the Carba NP test, when implemented with the standardized CLSI methodology, provides reproducible results across multiple sites for detection of carbapenemases.
Comparison of Whole-Genome Sequencing Methods for Analysis of Three Methicillin-Resistant Staphylococcus aureus Outbreaks
Cunningham, Scott A. , Jeraldo, Patricio , Quest, Daniel, Boxrud, Dave, Jenkins, Gregory D. , Drucker, Travis, Nelson, Heidi , Patel, Robin , Chia, Nicholas , Jeraldo, Patricio R , Quest, Daniel J, Drucker, Travis M, Chia, Nicholas , Johnson, Julie A. , Taylor, Angela , Chen, Jun , Patel, Robin , Cunningham, Scott A

Mayo Clinic

Journal of Clinical Microbiology | April 13, 2017 | Volume: 55 | Issue: 6 | Pages: 1946-1953

10.1128/jcm.00029-17 | PMID 28404677 Get It

ABSTRACT Whole-genome sequencing (WGS) can provide excellent resolution in global and local epidemiological investigations of Staphylococcus aureus outbreaks. A variety of sequencing approaches and analytical tools have been used; it is not clear which is ideal. We compared two WGS strategies and two analytical approaches to the standard method of SmaI restriction digestion pulsed-field gel electrophoresis (PFGE) for typing S. aureus . Forty-two S. aureus isolates from three outbreaks and 12 reference isolates were studied. Near-complete genomes, assembled de novo with paired-end and long-mate-pair (8 kb) libraries were first assembled and analyzed utilizing an in-house assembly and analytical informatics pipeline. In addition, paired-end data were assembled and analyzed using a commercial software package. Single nucleotide variant (SNP) analysis was performed using the in-house pipeline. Two assembly strategies were used to generate core genome multilocus sequence typing (cgMLST) data. First, the near-complete genome data generated with the in-house pipeline were imported into the commercial software and used to perform cgMLST analysis. Second, the commercial software was used to assemble paired-end data, and resolved assemblies were used to perform cgMLST. Similar isolate clustering was observed using SNP calling and cgMLST, regardless of data assembly strategy. All methods provided more discrimination between outbreaks than did PFGE. Overall, all of the evaluated WGS strategies yielded statistically similar results for S. aureus typing.
Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
Lachin, John M. , Bebu, Ionut , Bergenstal, Richard M. , Pop‐Busui, Rodica , Service, F. John, Nathan, David M., Zinman, Bernard , Nathan, David M., Pop-Busui, Rodica

Mayo Clinic

Diabetes Care | April 13, 2017 | Volume: 40 | Issue: 6 | Pages: 777-783

10.2337/dc16-2426 | PMID 28404658 Get It

OBJECTIVE The Diabetes Control and Complications Trial (DCCT) demonstrated the beneficial effects of intensive versus conventional therapy on the development and progression of microvascular complications of type 1 diabetes. These beneficial effects were almost completely explained by the difference between groups in the levels of HbA1c, which in turn were associated with the risk of these complications. We assessed the association of glucose variability within and between quarterly 7-point glucose profiles with the development and progression of retinopathy, nephropathy, and cardiovascular autonomic neuropathy during the DCCT. RESEARCH DESIGN AND METHODS Measures of variability included the within-day and updated mean (over time) of the SD, mean amplitude of glycemic excursions (MAGE), and M-value, and the longitudinal within-day, between-day, and total variances. Imputation methods filled in the 16.3% of expected glucose values that were missing. RESULTS Cox proportional hazards models assessed the association of each measure of glycemic variation, as a time-dependent covariate, with the risk of retinopathy and nephropathy, and a longitudinal logistic regression model did likewise for cardiovascular autonomic neuropathy. Adjusted for mean blood glucose, no measure of within-day variability was associated with any outcome. Only the longitudinal mean M-value (over time) was significantly associated with microalbuminuria when adjusted for the longitudinal mean blood glucose and corrected for multiple tests using the Holm procedure. CONCLUSIONS Overall, within-day glycemic variability, as determined from quarterly glucose profiles, does not play an apparent role in the development of microvascular complications beyond the influence of the mean glucose.
Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?
Sritharen, Yoginee, Enriquez‐Sarano, Maurice , Schaff, Hartzell V. , Casaclang‐Verzosa, Grace , Miller, Jordan D. , Enriquez-Sarano, Maurice , Schaff, Hartzell , Miller, Jordan

Mayo Clinic

Physiology | April 13, 2017 | Volume: 32 | Issue: 3 | Pages: 182-196

10.1152/physiol.00025.2016 | PMID 28404735 Get It

Our understanding of the fundamental biology and identification of efficacious therapeutic targets in aortic valve stenosis has lagged far behind the fields of atherosclerosis and heart failure. In this review, we highlight the most clinically relevant problems facing men and women with fibrocalcific aortic valve stenosis, discuss the fundamental biology underlying valve calcification and fibrosis, and identify key molecular points of intersection with sex hormone signaling.
Physiology in Perspective: The Importance of Integrative Physiology
Sieck, Gary C. , Sieck, Gary

Mayo Clinic

Physiology | April 12, 2017 | Volume: 32 | Issue: 3 | Pages: 180-181

10.1152/physiol.00009.2017 | PMID 28404734 Get It

Rising maternal circulating GH during murine pregnancy suggests placental regulation
Huang, Lili , Sim, Pamela Su-Lin, Roberts, Claire T. , Velhuis, Johannes D, Chen, Chen , Gatford, Kathryn L. , Mühlhäusler, Beverly Sara , Chen, C

Mayo Clinic

Endocrine Connections | April 12, 2017 | Volume: 6 | Issue: 4 | Pages: 260-266

10.1530/ec-17-0032 | PMID 28404685 Get It

Placenta-derived hormones including growth hormone (GH) in humans contribute to maternal adaptation to pregnancy, and intermittent maternal GH administration increases foetal growth in several species. Both patterns and abundance of circulating GH are important for its activity, but their changes during pregnancy have only been reported in humans and rats. The aim of the present study was to characterise circulating profiles and secretory characteristics of GH in non-pregnant female mice and throughout murine pregnancy. Circulating GH concentrations were measured in whole blood (2 μL) collected every 10 min for 6 h in non-pregnant diestrus female C57Bl/6J mice ( n = 9), and pregnant females at day 8.5–9.5 (early pregnancy, n = 8), day 12.5–13.5 (mid-pregnancy, n = 7) and day 17.5 after mating (late pregnancy, n = 7). Kinetics and secretory patterns of GH secretion were determined by deconvolution analysis, while orderliness and regularity of serial GH concentrations were calculated by approximate entropy analysis. Circulating GH was pulsatile in all groups. Mean circulating GH and total and basal GH secretion rates increased markedly from early to mid-pregnancy, and then remained elevated. Pulse frequency and pulsatile GH secretion rate were similar between groups. The irregularity of GH pulses was higher in all pregnant groups than that in non-pregnant mice. Increased circulating GH in murine pregnancy is consistent with an important role for this hormone in maternal adaptation to pregnancy and placental development. The timing of increased basal secretion from mid-pregnancy, concurrent with the formation of the chorioallantoic placenta and initiation of maternal blood flow through it, suggests regulation of pituitary secretion by placenta-derived factors.